Company Filing History:
Years Active: 2019-2021
Title: Michael E Stalhamer: Innovator in Pharmaceutically Active Formulations
Introduction
Michael E Stalhamer is a notable inventor based in Edison, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of water-soluble compounds designed for once-daily administration. With a total of 2 patents to his name, Stalhamer continues to push the boundaries of innovation in the pharmaceutical industry.
Latest Patents
Stalhamer's latest patents focus on a controlled absorption water-soluble pharmaceutically active organic compound formulation. This formulation is designed for oral administration and aims to provide a once-daily dosage. The composition includes a water-soluble pharmaceutically active organic compound that is incorporated into small particulates. Each particulate features a core of the active compound or an acceptable salt, which is in reversible association with a drug-binding polymer. The core is surrounded by an insoluble water-permeable membrane that delays the dissolution of the active compound, allowing for an extended release. This innovative formulation is designed to extend the release of the active compound for approximately 3 to 8 hours, making it suitable for compounds with a half-life of about 16 to 21 hours.
Career Highlights
Stalhamer is currently associated with Sti Pharma, LLC, where he applies his expertise in pharmaceutical formulations. His work has been instrumental in advancing the development of effective drug delivery systems that enhance patient compliance and therapeutic outcomes.
Collaborations
Some of Stalhamer's notable coworkers include David F Counts and Donald P Cox. Their collaborative efforts contribute to the innovative environment at Sti Pharma, LLC.
Conclusion
Michael E Stalhamer is a distinguished inventor whose work in pharmaceutically active formulations has the potential to significantly impact the pharmaceutical industry. His innovative approaches to drug delivery systems exemplify the importance of research and development in enhancing patient care.